Immunotherapy for hepatocellular carcinoma
US11597768B2 · kind B2 · utility
6Cited by
86References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2018 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Feb 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is method for the prevention, delay of progression or treatment of hepatocellular carcinoma in a subject, comprising administering to the subject in need thereof a therapeutically effective amount of an anti-PD-1 antibody, which is an antibody or a fragment antigen binding thereof, specifically binding to human PD-1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.